The European Union's pharmaceutical sector is in a constant state of evolution. With rigorous regulations, growing patient expectations, and the rapid pace of development, navigating this complex landscape requires a prudent approach. Pharmaceutical companies must evolve to these shifts by integrating innovative technologies, working with key stake